BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  Io Therapeutics, Inc., announces presentation of data from studies of its RAR gamma agonist compound IRX5010 in treatment of a mouse model of triple negative breast cancer, demonstrating combination treatment effects with an anti-PDL-1 monoclonal antibody checkpoint inhibitor

  December 12, 2024

   · 

  3 min read
• Press Releases

  Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million

  December 12, 2024

   · 

  12 min read
• Press Releases

  Fonseca Biosciences Secures Exclusive US Rights to XTORO® (finafloxacin otic suspension) 0.3% to Treat Swimmer’s Ear

  December 12, 2024

   · 

  2 min read
• Press Releases

  Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

  December 12, 2024

   · 

  4 min read
• Press Releases

  Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

  December 12, 2024

   · 

  10 min read
• Press Releases

  A2A Pharmaceuticals, Inc. Announces Phase 1 Clinical Trial Advancements in TACC3 Inhibition Program Targeting Multiple Cancers

  December 12, 2024

   · 

  2 min read
• Press Releases

  HUTCHMED Announces Breakthrough Therapy Designation in China for ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients After Disease Progression on EGFR Inhibitor Therapy

  December 12, 2024

   · 

  11 min read
• Press Releases

  BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering

  December 12, 2024

   · 

  4 min read
• Press Releases

  Long Read Sequencing Market Size Boosts 30.96% Solid CAGR to Hit USD 11.60 Billion by 2034

  December 12, 2024

   · 

  1 min read
• Press Releases

  KIND Presents Preclinical Results of AND017 in Animal Models of Sickle Cell Disease (SCD), Myelodysplastic Syndromes (MDS), and β-Thalassemia at the 66th American Society of Hematology Meeting and Exposition and Announces FDA Authorization of Investigational New Drug (IND) Application for AND017 for Clinical Trial in Sickle Cell Disease (SCD)

  December 12, 2024

   · 

  5 min read